* FMC Q1 net income up 9 pct on higher U.S. reimbursement

(Adds details on intravenous drugs unit Kabi, FMC anaemia drug)

The post UPDATE 1-Fresenius net profit up 24 percent on generic intravenous drugs appeared first on NASDAQ.